4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-018118
PRESIDENT AND CEO sold 60,000 shares at an average $53.09 ($3,185,280)
- PRESIDENT AND CEO acquired 60,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Torley Helen PRESIDENT AND CEO | 2025-06-20 | Option exercise 10b5-1 | +20,000 | $8.11 | $162,200 | 753,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-20 | Sale 10b5-1 | −20,000 | $52.96 | $1,059,200 | 733,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-23 | Option exercise 10b5-1 | +20,000 | $8.11 | $162,200 | 753,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-23 | Sale 10b5-1 | −20,000 | $52.57 | $1,051,460 | 733,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-24 | Option exercise 10b5-1 | +20,000 | $8.11 | $162,200 | 753,719 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-24 | Sale 10b5-1 | −4,489 | $53.11 | $238,406 | 749,230 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-24 | Sale 10b5-1 | −15,511 | $53.91 | $836,214 | 733,719 | D |
| Derivatives | |||||||
| Torley Helen PRESIDENT AND CEO | 2025-06-20 | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162,200 | 356,569 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-23 | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162,200 | 336,569 | D |
| Torley Helen PRESIDENT AND CEO | 2025-06-24 | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162,200 | 316,569 | D |
| Open-market sales · 60,000 sh · avg $53.09 · $3,185,280 | |||||||
Loading xslF345X05/form4-06242025_090608.xml…